The optimized priming effect of FGF ‐1 and FGF ‐2 enhances preadipocyte lineage commitment in human adipose‐derived mesenchymal stem cells
Genes to Cells · 2024
DOI: 10.1111/gtc.13095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Tanakorn Tarapongpun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Head Neck and Breast Surgery, Faculty of Medicine Siriraj Hospital, Department of Surgery, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 1, Mesenchymal Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Nanken-Kyoten TMDU, Siriraj Foundation, TMDU-MU JDP.
Abstract (Originalsprache)
The cell‐assisted lipotransfer technique, integrating adipose‐derived mesenchymal stem cells (ADMSCs), has transformed lipofilling, enhancing fat graft viability. However, the multipotent nature of ADMSCs poses challenges. To improve safety and graft vitality and to reduce unwanted lineage differentiation, this study refines the methodology by priming ADMSCs into preadipocytes—unipotent, self‐renewing cells. We explored the impact of fibroblast growth factor‐1 (FGF‐1), fibroblast growth factor‐2 (FGF‐2), and epidermal growth factor (EGF), either alone or in combination, on primary human ADMSCs during the proliferative phase. FGF‐2 emerged as a robust stimulator of cell proliferation, preserving stemness markers, especially when combined with EGF. Conversely, FGF‐1, while not significantly affecting cell growth, influenced cell morphology, transitioning cells to a rounded shape with reduced CD34 expression. Furthermore, co‐priming with FGF‐1 and FGF‐2 enhanced adipogenic potential, limiting osteogenic and chondrogenic tendencies, and possibly promoting preadipocyte commitment. These preadipocytes exhibited unique features: rounded morphology, reduced CD34, decreased preadipocyte factor 1 (Pref‐1), and elevated C/EBPα and PPARγ, alongside sustained stemness markers (CD73, CD90, CD105). Mechanistically, FGF‐1 and FGF‐2 activated key adipogenic transcription factors—C/EBPα and PPARγ—while inhibiting GATA3 and Notch3, which are adipogenesis inhibitors. These findings hold the potential to advance innovative strategies for ADMSC‐mediated lipofilling procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Head Neck and Breast Surgery, Faculty of Medicine Siriraj Hospital, Department of Surgery, Mahidol University, Bangkok, Thailand.
- Department of Stem Cell Regulation, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
- Department of Research, Faculty of Medicine Siriraj Hospital, Siriraj Research Group in Immunobiology and Therapeutic Sciences, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Tanakorn Tarapongpun
Förderung
- Nanken-Kyoten TMDU
- Siriraj Foundation
- TMDU-MU JDP
Zitieren
APA
Tarapongpun, T., Onlamoon, N., Tabu, K., Chuthapisith, S., & Taga, T. (2024). The optimized priming effect of FGF ‐1 and FGF ‐2 enhances preadipocyte lineage commitment in human adipose‐derived mesenchymal stem cells. Genes to Cells. https://doi.org/10.1111/gtc.13095
Vancouver
Tarapongpun T, Onlamoon N, Tabu K, Chuthapisith S, Taga T. The optimized priming effect of FGF ‐1 and FGF ‐2 enhances preadipocyte lineage commitment in human adipose‐derived mesenchymal stem cells. Genes to Cells. 2024. doi:10.1111/gtc.13095
BibTeX
@article{Tarapongpun2024,
author = {Tarapongpun, Tanakorn and Onlamoon, Nattawat and Tabu, Kouichi and Chuthapisith, Suebwong and Taga, Tetsuya},
title = {The optimized priming effect of FGF ‐1 and FGF ‐2 enhances preadipocyte lineage commitment in human adipose‐derived mesenchymal stem cells},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13095}
}
EUVIMED